McKesson Corporation $MCK Shares Bought by Brookstone Capital Management

Key Points

• Brookstone Capital Management increased its McKesson position by 15.9% in the third quarter, ending with 20,026 shares valued at approximately $17.1 million. Institutional investors collectively own 85.07% of the company.
• Analysts remain broadly positive, with 15 Buy ratings and four Holds; McKesson has a consensus “Moderate Buy” rating and an average price target of $997.12, while UBS raised its target to $1,200.
• McKesson reported quarterly revenue of $105.38 billion and EPS of $9.93, beating estimates, and declared a $0.94 quarterly dividend. Two executives also sold shares under pre-arranged Rule 10b5-1 plans, with insiders selling $1.16 million worth of stock during the quarter.

Brookstone Capital Management increased its position in shares of McKesson Corporation (NYSE:MCK - Free Report) by 15.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,026 shares of the company's stock after purchasing an additional 2,754 shares during the period. Brookstone Capital Management's holdings in McKesson were worth $17,098,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. BlackRock Inc. acquired a new stake in shares of McKesson in the second quarter valued at $8,156,743,000. Bank of America Corp DE purchased a new stake in shares of McKesson during the 2nd quarter worth $998,896,000. Legal & General Group Plc purchased a new position in shares of McKesson in the 2nd quarter valued at about $656,566,000. The Manufacturers Life Insurance Company purchased a new stake in McKesson during the second quarter worth approximately $651,462,000. Finally, Bank of New York Mellon Corp acquired a new stake in McKesson during the 2nd quarter worth $599,060,000. Hedge funds and other institutional investors own 85.07% of the company's stock.

Insider Activity at McKesson

In other McKesson news, EVP Francisco Fraga sold 800 shares of McKesson stock in a transaction that occurred on Thursday, October 15th. The shares were sold at an average price of $995.80, for a total transaction of $796,640.00. Following the transaction, the executive vice president directly owned 5,423 shares of the company's stock, valued at $5,400,223.40. The trade was a 12.86% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Napoleon B. Rutledge, Jr. sold 111 shares of the firm's stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total transaction of $98,950.95. Following the completion of the transaction, the chief accounting officer directly owned 521 shares in the company, valued at approximately $464,445.45. This represents a 17.56% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,212 shares of company stock valued at $1,164,182 over the last quarter. Insiders own 0.06% of the company's stock.

Analysts Set New Price Targets

MCK has been the topic of several research analyst reports. Citigroup lifted their price target on McKesson from $945.00 to $1,000.00 and gave the stock a "buy" rating in a research report on Friday, July 24th. Wells Fargo & Company increased their price objective on McKesson from $812.00 to $933.00 and gave the company an "equal weight" rating in a report on Tuesday, August 11th. UBS Group raised their target price on shares of McKesson from $1,080.00 to $1,200.00 and gave the stock a "buy" rating in a research report on Friday, October 16th. Mizuho lifted their target price on shares of McKesson from $905.00 to $1,020.00 and gave the company a "neutral" rating in a report on Tuesday. Finally, Morgan Stanley set a $977.00 price objective on McKesson in a research report on Tuesday, October 6th. Fifteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat, McKesson has an average rating of "Moderate Buy" and a consensus price target of $997.12.

McKesson Stock Performance

NYSE:MCK opened at $1,010.85 on Friday. McKesson Corporation has a 1 year low of $723.68 and a 1 year high of $1,030.27. The stock has a fifty day moving average price of $908.70 and a two-hundred day moving average price of $841.27. The stock has a market capitalization of $117.86 billion, a price-to-earnings ratio of 24.88, a PEG ratio of 2.02 and a beta of 0.30.

McKesson (NYSE:MCK - Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported $9.93 EPS for the quarter, topping the consensus estimate of $9.56 by $0.37. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The company had revenue of $105.38 billion for the quarter, compared to analyst estimates of $103.88 billion. During the same period in the previous year, the firm earned $8.26 EPS. The business's revenue was up 7.7% on a year-over-year basis. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. On average, analysts predict that McKesson Corporation will post 44.71 EPS for the current year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Tuesday, December 1st will be given a $0.94 dividend. This represents a $3.76 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Tuesday, December 1st. McKesson's dividend payout ratio is currently 10.06%.

More McKesson News

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Mizuho raised its price target for McKesson to $1,020, implying modest additional upside from recent trading levels. The upgrade follows the stock reaching a new one-year high and could support investor confidence. Mizuho raises McKesson price target
• Positive Sentiment: A recent analysis argues that artificial-intelligence initiatives and a potential FDA overhaul could become larger growth drivers for McKesson in 2027, potentially outweighing current regulatory headwinds. McKesson AI and FDA outlook
• Neutral Sentiment: McKesson declared a quarterly dividend of $0.94 per share, payable January 4, 2027, to shareholders of record December 1. The annualized payout is $3.76, representing a relatively low yield of about 0.4%, so the announcement is primarily a signal of continued shareholder returns rather than a major income catalyst. McKesson declares quarterly dividend
• Neutral Sentiment: Investor attention remains elevated after McKesson’s strong long-term performance and recent analyst upgrade, but elevated valuation and the stock’s proximity to its 52-week high may limit near-term upside. McKesson reaches one-year high
• Negative Sentiment: An insider, Francisco Fraga, reportedly sold 800 McKesson shares. The transaction is not necessarily a fundamental warning, but insider selling can weigh modestly on sentiment. McKesson insider share sale
• Negative Sentiment: Coverage of a McKesson-related security incident highlights potential cybersecurity and operational risks, which could add to investor concerns alongside regulatory uncertainty. McKesson security incident analysis

About McKesson

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson's principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.